Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.

Documenti analoghi

• Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.
  di: Jakob, G., et al.
  Pubblicazione: (1995)
• Cell surface protein disulfide isomerase regulates natriuretic peptide generation of cyclic guanosine monophosphate.
  di: Shuchong Pan, et al.
  Pubblicazione: (2014-01-01)
• The cyclic guanosine monophosphate/B-type natriuretic peptide ratio and mortality in advanced heart failure
  di: Lourenço, Patrícia, et al.
  Pubblicazione: (2009)
• Cell Surface Protein Disulfide Isomerase Regulates Natriuretic Peptide Generation of Cyclic Guanosine Monophosphate
  di: Pan, Shuchong, et al.
  Pubblicazione: (2014)
• The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction
  di: Palazzuoli, Alberto, et al.
  Pubblicazione: (2013)